aTYR PHARMA INC Fair Value Adjustment of Warrants
aTYR PHARMA INC (ATYR) reported Fair Value Adjustment of Warrants of -$29.00 thousand for the 12-month period ending 2015-12-31, per its 10-K filed 2018-03-20.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:FairValueAdjustmentOfWarrants · last filed 2018-03-20
- aTYR PHARMA INC fair value adjustment of warrants for the quarter ending 2015-12-31 was $0.00.
- aTYR PHARMA INC fair value adjustment of warrants for the quarter ending 2015-09-30 was $0.00, a 100.00% decline year-over-year.
- aTYR PHARMA INC fair value adjustment of warrants for the quarter ending 2015-06-30 was $48.00K, a 12.73% decline year-over-year.
- aTYR PHARMA INC fair value adjustment of warrants for the quarter ending 2015-03-31 was -$77.00K, a 356.67% decline year-over-year.
- aTYR PHARMA INC fair value adjustment of warrants for fiscal 2015 was -$29.00K.
- aTYR PHARMA INC fair value adjustment of warrants for fiscal 2014 was -$36.00K, a 228.57% decline from fiscal 2013.
- aTYR PHARMA INC fair value adjustment of warrants for fiscal 2013 was $28.00K.
| Period end | Fair Value Adjustment of Warrants 3 month | Fair Value Adjustment of Warrants 6 month | Fair Value Adjustment of Warrants 9 month | Fair Value Adjustment of Warrants 12 month |
|---|---|---|---|---|
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-20 | $0.00 derived: sum of 2 quarters · filed 2018-03-20 | $48.00K derived: sum of 3 quarters · filed 2018-03-20 | -$29.00K 10-K · filed 2018-03-20 |
| 2015-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-14 | $48.00K derived: sum of 2 quarters · filed 2016-11-14 | -$29.00K 10-Q · filed 2016-11-14 | -$278.00K derived: sum of 4 quarters · filed 2017-03-16 |
| 2015-06-30 | $48.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-10 | -$29.00K 10-Q · filed 2016-08-10 | -$278.00K derived: sum of 3 quarters · filed 2017-03-16 | -$150.00K derived: sum of 4 quarters · filed 2017-03-16 |
| 2015-03-31 | -$77.00K 10-Q · filed 2016-05-11 | -$326.00K derived: sum of 2 quarters · filed 2017-03-16 | -$198.00K derived: sum of 3 quarters · filed 2017-03-16 | -$143.00K derived: sum of 4 quarters · filed 2017-03-16 |
| 2014-12-31 | -$249.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-16 | -$121.00K derived: sum of 2 quarters · filed 2017-03-16 | -$66.00K derived: sum of 3 quarters · filed 2017-03-16 | -$36.00K 10-K · filed 2017-03-16 |
| 2014-09-30 | $128.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-10 | $183.00K derived: sum of 2 quarters · filed 2015-11-10 | $213.00K 10-Q · filed 2015-11-10 | |
| 2014-06-30 | $55.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-12 | $85.00K 10-Q · filed 2015-08-12 | ||
| 2014-03-31 | $30.00K 10-Q · filed 2015-06-18 | |||
| 2013-12-31 | $28.00K 10-K · filed 2016-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Quince Therapeutics, Inc. (QNCX) | United States | $0.031B | |
| CEL SCI CORP (CVM) | United States | $0.030B | -0.81 |
| Scilex Holding Co (SCLX) | United States | $0.042B | -0.14 |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B |